|
US20040081653A1
(en)
*
|
2002-08-16 |
2004-04-29 |
Raitano Arthur B. |
Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
|
|
US7480593B2
(en)
*
|
2005-08-03 |
2009-01-20 |
Suresh Gopalan |
Methods and systems for high confidence utilization of datasets
|
|
DK2069793T3
(en)
*
|
2006-08-29 |
2017-04-24 |
Oxford Biotherapeutics Ltd |
IDENTIFICATION OF PROTEIN IN CONNECTION WITH HEPATOCELLULAR CARCINOMA, GLIOBLASTOMA AND LUNG CANCER
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
JP2012513194A
(ja)
*
|
2008-12-23 |
2012-06-14 |
アストラゼネカ アクチボラグ |
α５β１に向けられた標的結合剤およびその使用
|
|
EP2379588A2
(en)
|
2008-12-30 |
2011-10-26 |
Cellartis AB |
The use of basigin-1 in stem cell and cancer applications
|
|
ME02842B
(me)
|
2009-03-05 |
2018-01-20 |
Squibb & Sons Llc |
Potpuno ljudska antitijela specifična za cadm1
|
|
US9441032B2
(en)
|
2010-04-07 |
2016-09-13 |
Agency For Science, Technology And Research |
Binding molecules against Chikungunya virus and uses thereof
|
|
EP2374816B1
(en)
*
|
2010-04-07 |
2016-09-28 |
Agency For Science, Technology And Research |
Binding molecules against Chikungunya virus and uses thereof
|
|
US9714294B2
(en)
|
2010-05-27 |
2017-07-25 |
Genmab A/S |
Monoclonal antibodies against HER2 epitope
|
|
CA3051311A1
(en)
|
2010-05-27 |
2011-12-01 |
Genmab A/S |
Monoclonal antibodies against her2
|
|
KR102810907B1
(ko)
|
2010-07-16 |
2025-05-21 |
아디맵 엘엘씨 |
항체 라이브러리
|
|
US9778264B2
(en)
|
2010-09-03 |
2017-10-03 |
Abbvie Stemcentrx Llc |
Identification and enrichment of cell subpopulations
|
|
CN106434561A
(zh)
*
|
2010-09-03 |
2017-02-22 |
艾伯维施特姆森特克斯有限责任公司 |
细胞亚群的鉴定和富集
|
|
BR112013005116A2
(pt)
|
2010-09-03 |
2019-09-24 |
Stem Centrx Inc |
moduladores e métodos de uso
|
|
MX347954B
(es)
*
|
2010-09-29 |
2017-05-19 |
Agensys Inc |
Conjugados de anticuerpo farmaco (adc) que enlazan a proteinas 191p4d12.
|
|
AU2015234335B2
(en)
*
|
2010-09-29 |
2017-09-28 |
Agensys, Inc. |
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
|
|
JOP20210044A1
(ar)
|
2010-12-30 |
2017-06-16 |
Takeda Pharmaceuticals Co |
الأجسام المضادة لـ cd38
|
|
CA2835603A1
(en)
*
|
2011-05-09 |
2012-11-15 |
Perseus Proteomics Inc. |
Antibody capable of specifically recognizing transferrin receptor
|
|
CN104302321A
(zh)
*
|
2011-12-05 |
2015-01-21 |
特瑞利斯生物科学有限责任公司 |
可用于被动流感免疫的抗体
|
|
DK2809681T3
(en)
*
|
2012-01-31 |
2019-03-11 |
Regeneron Pharma |
ANTI-ASIC1 antibodies and uses thereof
|
|
JP5939855B2
(ja)
*
|
2012-03-23 |
2016-06-22 |
国立大学法人 宮崎大学 |
トランスフェリン受容体抗体
|
|
EP2863946A4
(en)
*
|
2012-06-21 |
2016-04-13 |
Sorrento Therapeutics Inc |
ANTIGEN-BINDING PROTEINS THAT BIND TO C-MET
|
|
UY34887A
(es)
|
2012-07-02 |
2013-12-31 |
Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware |
Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
|
|
US9593165B2
(en)
*
|
2012-11-08 |
2017-03-14 |
University Of Miyazaki |
Antibody capable of specifically recognizing transferrin receptor
|
|
JP6467225B2
(ja)
*
|
2012-11-21 |
2019-02-06 |
Ｋｍバイオロジクス株式会社 |
新規なヒト抗ｉｌ−１８抗体
|
|
CN105209071A
(zh)
|
2013-03-14 |
2015-12-30 |
抗非特公司 |
用于提高疗效的基于鼻内递送中和抗体的组合物和方法
|
|
US9475874B2
(en)
|
2013-08-26 |
2016-10-25 |
MabVax Therapeutics, Inc. |
Nucleic acids encoding human antibodies to sialyl-lewisa
|
|
JP6552412B2
(ja)
|
2013-09-05 |
2019-07-31 |
国立大学法人 宮崎大学 |
ヒトインテグリンａ６ｂ４と特異的に反応する抗体
|
|
SI3508502T1
(sl)
|
2013-09-20 |
2023-07-31 |
Bristol-Myers Squibb Company |
Kombinacija anti-lag-3 protiteles in anti-pd-1 protiteles za zdravljenje tumorjev
|
|
ES2716685T3
(es)
|
2014-01-24 |
2019-06-14 |
Dana Farber Cancer Inst Inc |
Moléculas de anticuerpo para PD-1 y usos de las mismas
|
|
US10639370B2
(en)
|
2014-02-04 |
2020-05-05 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
KR102344390B1
(ko)
|
2014-02-04 |
2021-12-28 |
콘트라펙트 코포레이션 |
수동 인플루엔자 면역화에 유용한 항체, 및 이의 사용을 위한 조성물, 조합 및 방법
|
|
TWI777174B
(zh)
|
2014-03-14 |
2022-09-11 |
瑞士商諾華公司 |
針對lag-3之抗體分子及其用途
|
|
US20170173005A1
(en)
|
2014-03-27 |
2017-06-22 |
Research Foundation Of The City University Of New York |
Method for detecting or treating triple negative breast cancer
|
|
US9975960B2
(en)
*
|
2014-05-09 |
2018-05-22 |
Samsung Electronics Co., Ltd. |
Anti-HER2 antibody and anti-c-Met/anti-HER2 bispecific antibodies comprising the same
|
|
KR102401595B1
(ko)
*
|
2014-05-09 |
2022-05-24 |
삼성전자주식회사 |
항 HER2 scFv 단편 및 이를 포함하는 항 c-Met/항 HER2 이중 특이 항체
|
|
KR102536786B1
(ko)
|
2014-10-10 |
2023-05-26 |
이나뜨 파르마 에스.에이. |
Ｃｄ７３ 차단
|
|
MX385320B
(es)
|
2014-11-10 |
2025-03-18 |
Medimmune Ltd |
Moléculas de unión específicas para grupo de diferenciación 73 (cd73) y usos de las mismas.
|
|
HUE050596T2
(hu)
*
|
2014-11-21 |
2020-12-28 |
Bristol Myers Squibb Co |
Antitestek CD73 ellen és azok felhasználásai
|
|
LT3221346T
(lt)
|
2014-11-21 |
2020-11-10 |
Bristol-Myers Squibb Company |
Antikūnai, apimantys modifikuotas sunkiosios grandinės pastoviąsias sritis
|
|
EP3234598B1
(en)
|
2014-12-18 |
2019-11-06 |
F.Hoffmann-La Roche Ag |
Assay and method for determining cdc eliciting antibodies
|
|
EP3259288A1
(en)
*
|
2015-02-20 |
2017-12-27 |
Innate Pharma |
Cd73 blockade
|
|
AU2016258988A1
(en)
*
|
2015-05-04 |
2017-12-07 |
Cytomx Therapeutics, Inc |
Anti-ITGa3 antibodies, activatable anti-ITGa3 antibodies, and methods of use thereof
|
|
SG10202110908WA
(en)
|
2015-05-04 |
2021-11-29 |
Cytomx Therapeutics Inc |
Anti-cd166 antibodies, activatable anti-cd166 antibodies, and methods of use thereof
|
|
JP7420334B2
(ja)
*
|
2015-06-25 |
2024-01-23 |
株式会社カネカ |
液体注入方法
|
|
EP3322969B1
(en)
*
|
2015-07-15 |
2020-03-04 |
Becton, Dickinson and Company |
System and method for adjusting cytometer measurements
|
|
WO2017064043A1
(en)
|
2015-10-12 |
2017-04-20 |
Innate Pharma |
Cd73 blocking agents
|
|
WO2018013611A1
(en)
*
|
2016-07-11 |
2018-01-18 |
Corvus Pharmaceuticals, Inc. |
Anti-cd73 antibodies
|
|
EP3484923A1
(en)
|
2016-07-15 |
2019-05-22 |
Takeda Pharmaceutical Company Limited |
Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies
|
|
AU2017307610B2
(en)
|
2016-08-04 |
2023-10-05 |
Memorial Sloan-Kettering Cancer Center |
Cancer antigen targets and uses thereof
|
|
US10617720B2
(en)
*
|
2016-10-20 |
2020-04-14 |
Miltenyi Biotech, GmbH |
Chimeric antigen receptor specific for tumor cells
|
|
FI3548515T3
(fi)
|
2016-12-01 |
2026-03-04 |
Regeneron Pharma |
Radioleimattuja anti-PD-L1-vasta-aineita immuno-PET-kuvantamiseen
|
|
CA3046432A1
(en)
*
|
2016-12-13 |
2018-06-21 |
Astellas Pharma Inc. |
Anti-human cd73 antibody
|
|
PL3383916T3
(pl)
|
2017-01-24 |
2023-06-12 |
I-Mab Biopharma Us Limited |
Przeciwciała anty-cd73 i ich zastosowania
|
|
KR102713203B1
(ko)
|
2017-05-30 |
2024-10-10 |
브리스톨-마이어스 스큅 컴퍼니 |
Lag-3 양성 종양의 치료
|
|
KR20240155979A
(ko)
|
2017-05-30 |
2024-10-29 |
브리스톨-마이어스 스큅 컴퍼니 |
항-lag-3 항체 또는 항-lag-3 항체 및 항-pd-1 또는 항-pd-l1 항체를 포함하는 조성물
|
|
WO2018237173A1
(en)
|
2017-06-22 |
2018-12-27 |
Novartis Ag |
Antibody molecules to cd73 and uses thereof
|
|
EA202090247A1
(ru)
|
2017-07-14 |
2020-05-12 |
Цитомкс Терапьютикс, Инк. |
Антитела против cd166 и их применения
|
|
CN112739715A
(zh)
|
2018-01-12 |
2021-04-30 |
武田药品工业株式会社 |
抗cd38抗体的皮下给药
|
|
US20190292188A1
(en)
|
2018-02-27 |
2019-09-26 |
Incyte Corporation |
Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors
|
|
BR112020017382A2
(pt)
|
2018-03-09 |
2021-01-26 |
Agenus Inc. |
anticorpos anti-cd73 e métodos de uso dos mesmos
|
|
SG11202007199XA
(en)
|
2018-03-09 |
2020-09-29 |
Phanes Therapeutics Inc |
Anti-cd73 antibodies and uses thereof
|
|
MA52940A
(fr)
|
2018-05-18 |
2021-04-28 |
Incyte Corp |
Dérivés de pyrimidine fusionnés utilisés en tant qu'inhibiteurs de a2a/a2b
|
|
EP3569618A1
(en)
|
2018-05-19 |
2019-11-20 |
Boehringer Ingelheim International GmbH |
Antagonizing cd73 antibody
|
|
CN113166153B
(zh)
|
2018-07-05 |
2024-11-01 |
因赛特公司 |
作为a2a/a2b抑制剂的稠合吡嗪衍生物
|
|
WO2020020307A1
(en)
|
2018-07-25 |
2020-01-30 |
I-Mab Biopharma Co., Ltd. |
Anti-cd73 anti-pd-l1 bispecific antibodies
|
|
TWI894130B
(zh)
|
2018-12-03 |
2025-08-21 |
美商艾澤西公司 |
包含抗191p4d12抗體藥物結合物之醫藥組合物及其使用方法
|
|
KR102063341B1
(ko)
*
|
2018-12-31 |
2020-01-07 |
다이노나(주) |
Icam-1에 특이적으로 결합하는 항체 및 그의 용도
|
|
TWI829857B
(zh)
|
2019-01-29 |
2024-01-21 |
美商英塞特公司 |
作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
|
|
US12221484B2
(en)
|
2019-03-29 |
2025-02-11 |
Lankenau Institute For Medical Research |
Anti-NMDA receptor antibodies and methods of use
|
|
CA3154387A1
(en)
*
|
2019-09-13 |
2021-03-18 |
Tri-Institutional Therapeutics Discovery Institute, Inc. |
Anti-cd371 antibodies and uses thereof
|
|
WO2021053559A1
(en)
|
2019-09-18 |
2021-03-25 |
Novartis Ag |
Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapies
|
|
KR20220100963A
(ko)
*
|
2019-12-18 |
2022-07-18 |
에프. 호프만-라 로슈 아게 |
Hla-a2/mage-a4에 결합하는 항체
|
|
PH12022551621A1
(en)
|
2020-01-03 |
2023-10-23 |
Incyte Corp |
Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapy
|
|
TWI873265B
(zh)
|
2020-01-03 |
2025-02-21 |
美商英塞特公司 |
抗ｃｄ７３抗體及其用途
|
|
EP4088113A4
(en)
*
|
2020-01-12 |
2024-05-15 |
Vanderbilt University |
HUMAN ANTIBODIES AGAINST RIFT VALLEY FEVER VIRUS
|
|
CN111738980B
(zh)
*
|
2020-05-14 |
2023-08-04 |
北京深睿博联科技有限责任公司 |
一种医学影像的显示方法、计算机设备及存储介质
|
|
EP4159763A4
(en)
*
|
2020-05-29 |
2024-06-12 |
BrightPath Biotherapeutics Co., Ltd. |
ANTI-CD73 ANTIBODIES AND USE THEREOF
|
|
AU2021364837A1
(en)
|
2020-10-23 |
2023-05-25 |
Bristol-Myers Squibb Company |
Lag-3 antagonist therapy for lung cancer
|
|
KR20230157940A
(ko)
|
2020-12-29 |
2023-11-17 |
인사이트 코포레이션 |
A2a/a2b 저해제, pd-1/pd-l1 저해제 및 항-cd73 항체를포함하는 병용 요법
|
|
KR102887692B1
(ko)
*
|
2021-05-21 |
2025-11-18 |
주식회사 지놈앤컴퍼니 |
항-bcam 항체 또는 그의 항원 결합 단편
|
|
MX2023014695A
(es)
*
|
2021-06-08 |
2024-01-15 |
Merck Patent Gmbh |
Proteinas que unen cd80 y/o cd86 y ox40l.
|
|
EP4396236A4
(en)
|
2021-08-30 |
2025-10-01 |
Lassen Therapeutics 1 Inc |
ANTI-IL-11R ALPHA ANTIBODIES
|
|
CN114137231B
(zh)
*
|
2022-01-29 |
2022-04-29 |
北京大有天弘科技有限公司 |
一种血型不规则抗体的检测试剂盒及其应用
|
|
US12187806B2
(en)
|
2022-03-04 |
2025-01-07 |
Development Center For Biotechnology |
Anti-CD73 antibodies and use thereof
|
|
WO2024040194A1
(en)
|
2022-08-17 |
2024-02-22 |
Capstan Therapeutics, Inc. |
Conditioning for in vivo immune cell engineering
|
|
WO2024215624A2
(en)
*
|
2023-04-13 |
2024-10-17 |
A & G Pharmaceutical, Inc. |
Antibodies and conjugates against prostaglandin f2 receptor inhibitor and uses thereof
|
|
CN121666232A
(zh)
|
2023-05-31 |
2026-03-13 |
开普斯坦治疗公司 |
脂质纳米颗粒制剂和组合物
|
|
WO2025076113A1
(en)
|
2023-10-05 |
2025-04-10 |
Capstan Therapeutics, Inc. |
Ionizable cationic lipids with conserved spacing and lipid nanoparticles
|
|
WO2025076127A1
(en)
|
2023-10-05 |
2025-04-10 |
Capstan Therapeutics, Inc. |
Constrained ionizable cationic lipids and lipid nanoparticles
|
|
WO2025179294A2
(en)
|
2024-02-22 |
2025-08-28 |
Capstan Therapeutics, Inc. |
Immune engineering amplification
|
|
WO2025217454A2
(en)
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Ionizable cationic lipids and lipid nanoparticles
|
|
WO2025217452A1
(en)
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Constrained ionizable cationic lipids and lipid nanoparticles
|